|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase II/III | Phase III | Registration |
|---|
| Autoimmune | 1 | 2 | 2 | 0 | 1 | 0 | | Cancer | 1 | 4 | 2 | 1 | 0 | 0 | | Endocrine / Metabolic | 1 | 0 | 0 | 0 | 0 | 0 | | Infectious | 0 | 1 | 0 | 0 | 0 | 1 | | Inflammation | 2 | 3 | 1 | 0 | 0 | 0 | | Neurology | 0 | 0 | 1 | 0 | 0 | 0 | | Other | 0 | 0 | 0 | 0 | 1 | 0 | | Pulmonary | 2 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Toll-like receptor 9 (TLR9)